-
The Applications of 4,4'-Bis(N-carbazolyl)-1,1'-biphenyl
Time of Update: 2023-05-09
The high molecular weight, high charge mobility, and excellent thermal stability of BCB make it an ideal material for these applications.
The high molecular weight, high charge mobility, and excellent thermal stability of BCB make it an ideal material for these applications.
-
The medical device sector is active, with many stocks rising more than 10
Time of Update: 2023-01-05
The company is a company whose main business is the research and development, production, sales and service of medical device products, mainly covering two major business segments: health monitoring and renal medical care.
-
120 medical device companies released three quarterly reports, more than ninety percent earned
Time of Update: 2023-01-05
js?cdnversion='+~(-new Date()/36e5)];Data show that as of October 31, 120 medical device companies have released three quarterly reports, and more than ninety percent have achieved double growth in revenue and net profit.
-
461 pharmaceutical companies compete! The net profit of 23 companies exceeded 2 billion
Time of Update: 2022-11-15
doubled, in addition, more than 60 companies lost money; In terms of revenue, 37 companies exceeded 10 billion yuan, led by Shanghai Pharmaceutical and Jointown; From the perspective of gross profit margin, 14 companies exceeded 90%.
-
The long-term development of the pharmaceutical sector is optimistic, and these four subdivisions are worth paying attention
Time of Update: 2022-11-11
It is worth noting that up to now, dozens of multinational pharmaceutical and medical device companies have announced new actions in China at the fifth CIIE, including direct investment, cooperation with local enterprises, and localized production.
-
State Food and Drug Administration: Ensure the quality and safety of medical device transportation and storage, and promote the traceability of the whole process
Time of Update: 2022-11-04
The Appendix puts forward specific requirements for enterprises specializing in the transportation and storage of medical devices from the aspects of establishment and improvement of quality management system, institutions and personnel, facilities and equipment, computer information systems and quality responsibilities.
-
Ding Gangqiang, Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention: Improving nutritional status is the basis and guarantee for enhancing immunity
Time of Update: 2022-09-05
At the meeting, Ding Gangqiang, director of the Institute of Nutrition and Health of the Chinese Center for Disease Control and Prevention, delivered a keynote speech on "Nutrition Problems and Intervention Countermeasures in the New Situation - The Cornerstone of Reasonable Diet and Immunization" .
-
Within 1 day, many executives of pharmaceutical companies resigned
Time of Update: 2022-08-10
Celis Medical issued an announcement saying that the board of directors recently received a written resignation report submitted by the company's deputy general manager Huang Yongxi.
Celis Medical issued an announcement saying that the board of directors recently received a written resignation report submitted by the company's deputy general manager Huang Yongxi.
-
Professor Zhang Shilong took the "Guide" and opened up the road of clinical exploration
Time of Update: 2022-04-30
However, in real diagnosis and treatment scenarios, urinary tract The conditions of prostate cancer patients faced by surgeons are often more complex, which requires doctors to carry out individualized treatment according to the actual situation, and also requires doctors to continuously verify and explore the guidelines according to practice .
-
The scope of use of the new crown self-test kit announced that the effectiveness of antigen detection can reach up to 99
Time of Update: 2022-04-25
Not only that, on the second day after the opening of the domestic antigen reagent market, the State Food and Drug Administration issued the "Notice on Doing a Good Job in the Quality and Safety Supervision of New Coronavirus Antigen Detection Reagents", requiring the strengthening of registration-related management, production and operation.
-
Supporting the submission of new drug applications this year, the key clinical trial results of innovative RNAi therapy are positive
Time of Update: 2021-11-13
The trial reached the primary endpoint, that is, nedosiran caused a statistically significant decrease in urine oxalate excretion (Uox) in patients with PH1 subtype compared with placebo .
-
The citizens of Wuhan ushered in hundreds of price-cut drugs, including 61 nationally selected varieties
Time of Update: 2021-10-21
It is reported that starting from October 10th, citizens of Wuhan ushered in 113 types of medicines at reduced prices, including 61 nationally selected varieties, 19 alliance-purchased varieties, and 33 medicines that were successfully renewed by Wuhan municipal centralized procurement .
-
The FDA has raised prices again
Time of Update: 2021-08-28
943 million US dollars, the marketing application fee for new drugs that do not require clinical research is 1.
1 million US dollars, and the application fee for new drugs that do not require clinical research has risen to about 1.
-
Sixiang Unlimited and Jada Hexin reached a strategic cooperation and officially entered the medical aesthetics market
Time of Update: 2021-07-08
These AI technologies and live broadcast tools can help users to accurately determine their medical beauty plans and prioritize their beauty before they contact the more than 200 medical beauty institutions on the Jada Hexin medical beauty platform .
-
BMJ: Data collection of over 100 million people in 8 countries to discuss adverse events after COVID-19 vaccination
Time of Update: 2021-06-21
n1435 (Published 14 June 2021)Cite this as: BMJ 2021;373:n1435 References: Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study BMJ 2021; 373 doi: https://doi .
